4T2-32669-30422
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Oxygen saturation decreased, Tachycardia — Feeling: Fair · Fatigue or tirednessFree text: Tachycardia, difficulty taking deep breath intermittently with slightly decreased SpO2 just like I had during Covid illness .MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Pre-existing disease — Feeling: Fair · Fatigue or tirednessFree text: Difficulty breathing , intermittent , had to use an inhaler . Similar to my acute covid symptoms in March but much milderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Health check-in — day 7, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-20
- 2021-01-27
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-01
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Fair · Fatigue or tirednessFree text: PalpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-14
- 2021-02-21
- 2021-02-27
- 2021-03-05
- 2021-03-12
- 2021-05-01
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Frequent flares of cold sores and shingles . Shortness of breath on exertion and increased exercise intolerance .MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-12
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Arthritis, Exposure to SARS-CoV-2, Herpes zoster, Viral rash, Weight increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Significant weight gain Shingles outbreak Inflammatory arthritis Viral exanthem after Covid exposureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-01
- 2022-02-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Tachycardia, difficulty taking deep breath intermittently with slightly decreased SpO2 just like I had during Covid illness .
Systemic reaction (other): Difficulty breathing , intermittent , had to use an inhaler . Similar to my acute covid symptoms in March but much milder
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Palpitations
Release 9 — 6 months, dose 2
Symptoms: Frequent flares of cold sores and shingles . Shortness of breath on exertion and increased exercise intolerance .
Release 11 — 12 months, dose 2
Symptoms: Significant weight gain Shingles outbreak Inflammatory arthritis Viral exanthem after Covid exposure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthritis | · | · | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Dyspnoea exertional | ✓ | · | ✓ |
| SD | Exercise tolerance decreased | ✓ | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Viral rash | · | · | ✓ |
| SD | Weight increased | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Oxygen saturation decreased | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release